Mechanical and thermal hyperalgesia (pain hypersensitivity) are cardinal signs of inflammation. Although the mechanism underlying thermal hyperalgesia is well understood, the cellular and molecular basis of mechanical hyperalgesia is poorly described. Here, we have identified a subset of peptidergic C-fiber nociceptors that are insensitive to noxious mechanical stimuli under normal conditions but become sensitized to such stimuli when exposed to the inflammatory mediator nerve growth factor (NGF). Strikingly, NGF did not affect mechanosensitivity of other nociceptors. We show that these mechanoinsensitive ''silent'' nociceptors are characterized by the expression of the nicotinic acetylcholine receptor subunit alpha-3 (CHRNA3) and that the mechanically gated ion channel PIEZO2 mediates NGF-induced mechanosensitivity in these neurons. Retrograde tracing revealed that CHRNA3 + nociceptors account for $50% of all peptidergic nociceptive afferents innervating visceral organs and deep somatic tissues. Hence, our data suggest that NGFinduced ''un-silencing'' of CHRNA3 + nociceptors significantly contributes to the development of mechanical hyperalgesia during inflammation.
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In Brief
Prato et al. find that mechanoinsensitive nociceptors account for 50% of all nociceptors in visceral organs and deep somatic tissues and are sensitized to mechanical stimuli by the inflammatory mediator NGF, suggesting that they significantly contribute to inflammationinduced mechanical hyperalgesia. 
INTRODUCTION
The somatosensory nervous system comprises a remarkable variety of neurochemically and functionally diverse sensory afferents that enable us to detect and discriminate a wide range of tactile and noxious stimuli Lechner and Lewin, 2013) . Sensory neurons that are activated by noxious stimuli are termed nociceptors and are subclassified into unmyelinated C-fiber nociceptors and myelinated A-fiber nociceptors. The vast majority of all nociceptors are sensitive to mechanical stimuli, but various subpopulations with different sensitivities to additional noxious stimuli have been described in a wide variety of species. Nociceptors that are exclusively activated by mechanical stimuli are termed C-fiber and A-fiber mechanonociceptors; those that additionally respond to noxious thermal stimuli are collectively termed polymodal nociceptors but can be further subclassified according to their specific sensitivity to noxious heat and/or cold Lewin and Moshourab, 2004) .
The contribution of the various nociceptor subpopulations to different forms of acute pain is quite well understood. C-fiber nociceptors that express the heat-gated ion channel TRPV1, for example, are required for the detection of noxious heat and for the development of heat hyperalgesia (increased pain sensitivity to heat) (Brenneis et al., 2013; Cavanaugh et al., 2009) , and one study also implicated TRPV1 + afferents in the detection of noxious pinch stimuli (Brenneis et al., 2013) . Moreover, it has been shown that noxious cold is detected by C-fiber nociceptors that express the cold-and menthol-sensitive ion channel TRPM8 (Knowlton et al., 2013) . Last, whereas noxious mechanical stimuli applied with a blunt probe, such as a von Frey hair, are detected by C-fiber nociceptors that express the Mas-related G protein-coupled receptor D (Cavanaugh et al., 2009) , sharp and potentially tissue damaging mechanical stimuli, such as a pinprick, are detected by a subset of A-fiber mechanonociceptors that are characterized by the expression of the neuropeptide Y receptor type 2 (Arcourt et al., 2017) . However, one subpopulation of nociceptors, the so-called silent nociceptors, has remained enigmatic ever since it was first described (Gold and Gebhart, 2010; Michaelis et al., 1996) . The term ''silent nociceptor'' was originally introduced to describe sensory afferents that fired action potentials in response to electrical stimulation of the receptive field but could not be activated by physiologically relevant noxious mechanical stimuli. Silent nociceptors have been found in large numbers in the urinary bladder, the distal colon, and the knee joint (Feng and Gebhart, 2011; Gebhart, 1999; Hä bler et al., 1990; Schaible and Schmidt, 1988) but are rare in rodent skin (Wetzel et al., 2007) . In human skin, however, silent afferents account for almost one quarter of all C-fiber nociceptors (Schmidt et al., 1995) . The fact that silent nociceptors are normally not activated by mechanical stimuli, suggests that they are not involved in mechanical pain signaling in healthy individuals. However, several studies have shown that silent afferents are sensitized to mechanical stimuli by a variety of compounds that are commonly used to experimentally induce inflammation, as well as by endogenous inflammatory mediators such as nerve growth factor (NGF) (Feng et al., 2012; Gold and Gebhart, 2010; Hirth et al., 2013; Schaible and Schmidt, 1985) . Considering the large proportion of mechanically insensitive afferents in the aforementioned tissues, it is conceivable that un-silencing them would greatly increase nociceptive input to pain processing circuits in the spinal cord and higher brain regions. Accordingly it has been proposed that silent afferents may significantly contribute to mechanical hyperalgesia during inflammation (Gold and Gebhart, 2010) . However, because of the lack of molecular markers that would allow the unequivocal identification or the selective functional manipulation of silent afferents, this hypothesis has never been directly tested. Moreover, the molecular mechanism that mediates the un-silencing of silent nociceptors has not yet been described.
RESULTS

CHRNA3
+ Sensory Neurons Are Mechanoinsensitive Peptidergic C-Fiber Nociceptors Mechanosensitivity of dorsal root ganglion (DRG) sensory neurons is usually examined using the patch-clamp technique by recording whole-cell transmembrane currents evoked by mechanical stimulation of the cell soma ( Figure 1A ). In DRG neurons, three types of mechanically activated currents, which differ in their inactivation kinetics and were thus termed rapidly adapting (RA), intermediately adapting (IA), and slowly adapting (SA) currents, have been described (Drew et al., 2002; Hu and Lewin, 2006; McCarter et al., 1999; Ranade et al., 2014) . The ion channel PIEZO2 mediates the RA current in low-threshold mechanoreceptors (LTMRs), which detect tactile stimuli, but the mechanically gated channel required for mechanotransduction in nociceptors is still unknown (Ranade et al., 2014; SchrenkSiemens et al., 2015) . While we were screening several reporter mouse lines with the original goal of testing whether IA and SA currents are confined to genetically defined subsets of nociceptors, we made the observation that neurons in which EGFP is expressed under the control of the promoter of the nicotinic acetylcholine receptor subunit alpha-3 (CHRNA3) do not respond to mechanical stimuli at all. Thus only 1 of 15 tested CHRNA3 + cells exhibited a tiny inward current in response to mechanical stimulation of the soma ( Figures 1B-1D ). In contrast, the majority of peptidergic C-fiber nociceptors (27 of 32 tested neurons), non-peptidergic nociceptors (13 of 17), and LTMRs (18 of 21) exhibited large mechanically evoked inward currents ( Figures 1B-1D ), which was consistent with previously published data (Drew et al., 2002; Hu and Lewin, 2006; Ranade et al., 2014) . In these recordings, LTMRs and nociceptors were distinguished by means of cell size as well as action potential (AP) shape and duration, as previously described (Fang et al., 2005; Koerber et al., 1988) . Peptidergic and non-peptidergic nociceptors were further discriminated by isolectin B4 (IB4) labeling, which specifically binds to non-peptidergic nociceptors ( Figure 1E ) . Thus, small-diameter IB4-negative neurons with wide APs that exhibited the nociceptor-specific hump in the falling phase were classified as peptidergic C-fiber nociceptors, and large-diameter neurons with narrow uninflected spikes were classified as LTMRs ( Figures 1E-1G ). CHRNA3 + neurons exhibited APs that were indistinguishable from those of other nociceptors but were significantly different from the APs of LTMRs ( Figures 1F and 1G ). Moreover, CHRNA3 + neurons were not labeled by IB4 ( Figure 1E ), had small to medium-size cell bodies, and accounted for 7.8% ± 1.6% (n = 636) of the total population in cultures of L2-L5 DRGs ( Figure 1H ). To test if CHRNA3 + neurons, as suggested by their AP configuration, are indeed nociceptors, we next examined the expression of well-established nociceptor subpopulation markers in CHRNA3 + neurons in L3-L5 DRGs (Figures 2A-2D ).
The great majority of CHRNA3 + neurons expressed the NGF receptor TRKA (94.6% ± 4.1%; Figures 2A and 2D ) and the calcitonin gene-related peptide (CGRP) (90.5% ± 2.5%; Figures 2C  and 2D ), which are markers for peptidergic nociceptors (Averill et al., 1995) , but did not express the glial cell line-derived neurotrophic factor (GDNF) receptor RET (1.8% ± 3.0%; Figures 2B  and 2D ), which is present in non-peptidergic neurons . Moreover, only a few CHRNA3 + neurons showed immunoreactivity for neurofilament heavy polypeptide (NEFH) (11.6% ± 5.4%; Figures 2A and 2D) , which is expressed only in myelinated sensory neurons. The central projections of CHRNA3 + neurons predominantly terminated in lamina I of the dorsal horn of the spinal cord, which is also characteristic of peptidergic nociceptors ( Figure 2E ). We also observed EGFP immunoreactivity in local neurons in lamina II o of the dorsal horn and scattered throughout lamina III. However, unlike the EGFP signals in lamina I, the signals in deeper laminae did not overlap with CGRP immunofluorescence (see insets in Figure 2E ) and thus unlikely originate from CHRNA3 + sensory afferents.
Hence the electrophysiological data together with the immunohistochemical analysis strongly suggest that CHRNA3 + neurons are mechanically insensitive, ''silent,'' peptidergic C-fiber nociceptors.
+ Neurons Densely Innervate Deep Somatic Tissues and Viscera but Are Absent from the Skin Silent nociceptors have originally not only been found in the knee joint (Schaible and Schmidt, 1985) , which is innervated by L3-L4 DRG neurons that we had investigated so far, but were shown to be even more abundant in visceral organs (Michaelis et al., 1996) . Hence we next examined CHRNA3 expression in other spinal segments. Indeed, CHRNA3
+ neurons were present in all DRGs from cervical (C1) to sacral (S1), and almost all of them expressed CGRP ( Figures 2F and S1A and lumbosacral (L6-S1) DRGs ( Figures 2F and 2G ). This finding strongly supports our hypothesis that CHRNA3 + neurons are silent nociceptors, because these DRGs give rise to the lumbar splanchnic nerve and the pelvic nerve, which innervate the colon and the bladder, where silent afferents have been found in large numbers (Christianson et al., 2007; Michaelis et al., 1996) . While analyzing the immunolabeled sections, we noticed the presence of numerous neurons with extremely bright GFP fluorescence in lumbosacral DRGs ( Figures 2F and S1B) . Indeed, the GFP intensity distributions in L6-S1 DRGs and in T12-L1 DRGs were best fit with the sum of two Gaussians, whereas they were better fitted with a single Gaussian in all other DRGs, suggesting that two different populations of CHRNA3 + neurons that significantly differ in their GFP intensities (hereafter termed GFP low and GFP high neurons) are present in thoracolumbar and lumbosacral DRGs ( Figure S1C ). GFP low neurons had significantly higher levels of CGRP compared with GFP high neurons ( Figure S1D ), suggesting that these two populations may also differ in their functional properties. To test this hypothesis, we examined the mechanosensitivity of the two populations in various spinal segments. GFP low neurons from all spinal segments as well as GFP high neurons from the thoracolumbar region were insensitive to mechanical stimuli, whereas GFP high neurons from lumbosacral DRGs exhibited large mechanotransduction currents (Figures S2A and S2B (Feng and Gebhart, 2011; Gebhart, 1999; Hä bler et al., 1990; Schaible and Schmidt, 1988) .
+ Neurons Are Sensitized to Mechanical Stimuli by NGF A key feature of silent nociceptors is their ability to become sensitized to mechanical stimuli by inflammatory mediators. We thus next asked if CHRNA3 + (GFP low from L2-L5 DRGs) neurons acquire mechanosensitivity after treatment with NGF (50 ng/mL) or an inflammatory soup containing 10 mM bradykinin, 10 mM prostaglandin E 2 , 10 mM histamine, and 10 mM serotonin. One hour treatment with NGF or the inflammatory soup did not affect mechanosensitivity of CHRNA3 + neurons (Figures 5A-5C and S4; note that both treatments were applied after the cells had been cultured in normal growth medium for 24 hr). After 24 hr treatment with NGF, however, CHRNA3 + neurons acquired mechanosensitivity and responded to mechanical stimulation with large inward currents, which did not further increase when NGF and inflammatory soup were applied together (Figures 5A-5C and S4). Interestingly, NGF did not modulate the amplitude or the kinetics of mechanotransduction currents in small-diameter IB4-negative neurons, that is, putative TRKA-expressing peptidergic C-fiber nociceptors ( Figures 5D-5F ). Inflammatory soup alone also had no effect on mechanosensitivity of IB4-negative neurons. However, after 24 hr treatment with NGF, 1 hr treatment with the inflammatory soup caused a small but significant increase of mechanotransduction current amplitudes elicited by small membrane displacements ( Figure 5E ), as well as a slowing of inactivation kinetics ( Figure 5F ). Via binding to the TRKA receptor, NGF can activate multiple signaling pathways, including the PLCg pathway, the PI3-kinase pathway, and the Ras/Raf/MEK/ERK pathway (Denk et al., 2017) . To examine which of these signaling pathways mediated the sensitization of CHRNA3 + neurons, we next incubated DRG cultures for 24 hr with NGF in the presence of 5 mM U73122, a PLCg blocker, 500 nM wortmannin (WTM), a PI3-kinase blocker, or 10 mM U0126, an ERK1/2 blocker ( Figure 6A ). U73122 and WTM did not alter the effect of NGF treatment, but CHRNA3 + neurons treated with U0126 exhibited significantly smaller mechanotransduction currents than neurons from the same cultures treated with NGF alone ( Figure 6B ). ERK1/2 kinases can regulate gene transcription but can also directly modulate ion channels by phosphorylation. To test if the former mechanism is involved, we incubated CHRNA3 + neurons for 24 hr with NGF in the presence of the transcription blocker actinomycin D (2 mg/mL). Indeed, mechanotransduction currents were significantly smaller when cultures were treated with actinomycin D (Figure 6B ), suggesting that de novo gene transcription is required for the NGF-induced acquisition of mechanosensitivity in CHRNA3 + neurons.
We next sought to identify the ion channel that confers mechanosensitivity on CHRNA3 + neurons. In LTMRs, RA-type mechanotransduction currents are mediated by PIEZO2, but the ion channel that mediates mechanotransduction currents in nociceptors is still unknown (Ranade et al., 2014) . Several proteins have been implicated in mechanosensitivity of sensory neurons such as the acid-sensing ion channels ASIC2 and ASIC3 (Price et al., 2000 (Price et al., , 2001 , the transient receptor potential channels TRPA1 (Vilceanu and Stucky, 2010) , TRPC3 and TRPC6 (Quick et al., 2012) and TMEM150c (Hong et al., 2016) , but conflicting results have been published regarding their precise role in mechanotransduction (Drew et al., 2004; Dubin et al., 2017) . To test if any of these putative mechanotransduction genes was present in CHRNA3 + neurons and upregulated by NGF, we next compared their mRNA levels in CHRNA3 + neurons from L2-L5 DRGs cultured for 24 hr in the presence and absence of NGF using qPCR ( Figure 7A ). This analysis showed that transcripts for none of these proteins were upregulated by NGF. Unexpectedly, however, the qPCR data revealed that even under proportions of individual mice are shown as black circles). Note that CHRNA3-GFP low (mechanoinsensitive) afferents account for $50% of all CGRP + afferents in the bladder, colon, and knee joint.
significantly slower inactivation kinetics at positive membrane potentials ( Figures 7C-7E) . Moreover, mechanotransduction currents in CHRNA3 + neurons were inhibited by the toxin GsMTx4 ( Figure 7F ), which had been shown to block PIEZO2 currents (Wang et al., 2017) . Finally, small interfering RNA (siRNA)-mediated knockdown of PIEZO2 expression in CHRNA3 + neurons prevented the acquisition of mechanosensitivity in NGF-treated cells ( Figures 7G and 7H) .
In summary, our data show that PIEZO2 confers mechanosensitivity to CHRNA3 + neurons. However, because PIEZO2 is also expressed in the absence of NGF (i.e., under conditions in which CHRNA3 + neurons do not exhibit mechanotransduction currents) our data further suggest that PIEZO2 is normally inhibited in these cells and is released from this inhibition by NGF-induced upregulation of a yet unidentified protein ( Figure 7I ). Figure S4 . 
DISCUSSION
Here, we have identified a molecular marker for mechanoinsensitive ''silent'' nociceptors. We show that sensory neurons that express CHRNA3 constitute a subset of peptidergic C-fiber nociceptors that are completely insensitive to mechanical stimuli under normal conditions but become sensitized to such stimuli when exposed to the inflammatory mediator NGF. Strikingly, the mechanosensitivity of other nociceptors does not appear to be affected by NGF treatment. We further show that the mechanically gated ion channel PIEZO2 mediates NGFinduced mechanosensitivity in CHRNA3 + nociceptors. Because CHRNA3 + afferents account for $50% of all peptidergic nociceptors innervating visceral organs and deep somatic tissues, we propose that the NGF-induced un-silencing of CHRNA3 + afferents significantly contributes to the development of mechanical hyperalgesia during inflammation.
The Contribution of CHRNA3 + Neurons to InflammationInduced Mechanical Hyperalgesia NGF plays an important role in the induction and maintenance of pain hypersensitivity associated with inflammation (Denk et al., 2017; Lewin et al., 2014) , which is highlighted by several important observations. Thus, a single NGF injection induces profound and long-lasting thermal and mechanical hyperalgesia in rodents and humans (Dyck et al., 1997; Lewin et al., 1993; Rukwied et al., 2010) . Moreover, sequestering endogenously produced NGF with anti-NGF antibodies blocks hyperalgesia associated with experimentally induced inflammation in rodents (Woolf et al., 1994) and, most important, alleviates pain in humans suffering from a variety of painful chronic inflammatory diseases (Chang et al., 2016; Denk et al., 2017) . Although the mechanism underlying NGF-induced heat hyperalgesia is well understood, little is known about the cellular and molecular basis of mechanical hyperalgesia. Our data suggest that CHRNA3 + silent nociceptors may contribute to the development of inflammatory mechanical hyperalgesia in visceral organs, muscles, and joints, via the following mechanism: under normal conditions, CHRNA3 + neurons are mechanoinsensitive ( Figures 1A-1D ), and hence noxious mechanical stimuli only activate other mechanosensitive nociceptors, leading to normal pain perception ( Figure 7I ). During inflammation, however, increased NGF levels in the inflamed tissues (Chen et al., 2016; Denk et al., 2017) lead to unsilencing of CHRNA3 + afferents ( Figures 5A-5C ). Considering that silent afferents account for $50% of all nociceptors in these tissues (Figure 4 ), the consequence of this un-silencing is that the number of nociceptive afferents that are activated by a given noxious mechanical stimulus is doubled, which inevitably results in significantly increased excitatory drive onto projection neurons in the spinal cord and hence to increased pain sensitivity ( Figure 7I) . So is this model in accordance with previously published data and models regarding possible mechanisms of mechanical hyperalgesia? First, we would like to emphasize that we do not claim that the un-silencing of CHRNA3 + afferent is the only mechanism underlying NGF-induced hyperalgesia. Our findings do not rule out a possible contribution of previously described mechanisms such as NGF-induced increases in the synthesis and release of brain-derived neurotrophic factor (BDNF) from the central synapses of nociceptors, which leads to strengthened synaptic transmission and hence amplified pain signaling, or NGF-induced changes in the electrical excitability of nociceptors resulting from subtle changes in the expression levels and the functional properties of the voltage-gated sodium channels Nav1.7 and Nav1.8 (Lewin et al., 2014; Pezet and McMahon, 2006) . However, given the remarkable sensitivity to NGF (Figure 5 ) and the high incidence of CHRNA3 + afferents in viscera and deep somatic tissues (Figures 3 and 4) , it is tempting to speculate that the contribution of CHRNA3 + afferents to pain hypersensitivity in these tissues is quite considerable. Indeed, there is compelling clinical evidence indicating that NGFsignaling plays a particularly important role in the development of pain hypersensitivity in the joints, in the bladder, and in muscles. Thus numerous clinical trials have demonstrated that anti-NGF therapy shows particularly great efficacy in alleviating pain associated with osteoarthritis, interstitial cystitis, and low back pain (Chang et al., 2016; Denk et al., 2017) . Our observation that mechanoinsensitive CHRNA3 + afferents account for approximately 50% of all peptidergic nociceptors in the colon, the bladder, the knee joint, and muscles ( Figures 3 and 4) is consistent with previous electrophysiological studies, which found that the proportion of silent afferents among C-fiber nociceptors is between 30% and 90% in these tissues (Feng and Gebhart, 2011; Gebhart, 1999; Gold and Gebhart, 2010; Hä bler et al., 1990; Michaelis et al., 1996; Schaible and Schmidt, 1985) . Silent afferents have also been found in large numbers ($25%) in cutaneous nerves of humans and monkeys (Meyer et al., 1991; Schmidt et al., 1995) , but they appear to be extremely rare (<10% of all C-fiber nociceptors) in the mouse skin (Wetzel et al., 2007) . Hence, the absence of CHRNA3 + afferents from both hairy and glabrous skin ( Figures 3A and S3A) was not fully unexpected. It is unlikely that we overlooked CHRNA3 + afferents innervating the skin, considering that we have analyzed a total of 120 skin sections from three different mice. Hence, we propose that silent cutaneous afferents are genetically different from those innervating the viscera and deep somatic tissues.
The Effects of NGF on Mechanosensitivity
Another important finding of our study was that NGF sensitizes only CHRNA3 + neurons but not other TRKA-expressing nociceptors (IB4 neg neurons), to mechanical stimuli ( Figure 5 ). At first glance, the finding that IB4 neg neurons are not sensitized to mechanical stimuli appears to contradict previous reports from others and us, showing that mechanotransduction currents in IB4 neg neurons are modulated by NGF (Di Castro et al., 2006; Lechner et al., 2009) . In this context, it is important to note that here we have used adult animals (8-12 weeks old), whereas in our previous study, we examined neurons from newborn mice ( rats. However, it is well known that NGF is important for the functional maturation of sensory neurons during embryonic and postnatal development of sensory neurons (Lewin et al., 2014; Luo et al., 2007) . We have actually shown that NGF is required for the developmental acquisition of mechanosensitivity in IB4 neg neurons (Lechner et al., 2009 ). Moreover, it was shown that the diversification of nociceptors into peptidergic TRKA + neurons and non-peptidergic TRKA -/RET + neurons is only completed 3 weeks after birth (Bennett et al., 1996; . Hence NGF-dependent effects observed in newborn or juvenile animals should be interpreted with caution, as they might solely reflect incomplete maturation of nociceptors. Indeed, using extracellular single-unit recordings from the saphenous nerve, it was recently shown that in the complete Freund's adjuvant (CFA) model of inflammation, peripheral sensitization of cutaneous nociceptors occurs only in young but not in aged mice (Weyer et al., 2016) . So does that mean that the mechanosensitivity of CHRNA3-negative peptidergic nociceptors is not at all altered during inflammation and that NGF does not in general modulate the functional properties of these neurons? Not quite. Although our data show that NGF does not directly modulate mechanotransduction currents in IB4 neg neurons, we demonstrate that an inflammatory soup potentiates mechanotransduction currents only after pretreatment with NGF ( Figure 5E ). A possible explanation for this observation is that NGF upregulates the expression of genes that are required for the actions of other inflammatory mediators. Indeed, it has been shown that the B2 receptor for bradykinin, which was present in the inflammatory soup used in this study, is upregulated in nociceptors by NGF (Lee et al., 2002) . Moreover, Di Castro et al. (2006) showed that in juvenile rats, direct activation of protein kinase C with the phorbol ester PMA sensitizes mechanotransduction currents in IB4 neg neurons only after pretreatment with NGF. Hence, we conclude that in addition to inducing a complete phenotypic switch in CHRNA3 + neurons, NGF primes other peptidergic nociceptors for subsequent sensitization by other inflammatory mediators, which, however, have only moderate effects on mechanosensitivity.
The Molecular Basis of NGF-Induced Mechanosensitivity in CHRNA3 + Neurons
During the past two decades, numerous ion channels, such as ASIC channels, TRPA1, TRPC3, TRPC6, TMEM150c, and PIEZO2, have been proposed to contribute to mechanosensitivity of sensory neurons (Hong et al., 2016; Price et al., 2000 Price et al., , 2001 Quick et al., 2012; Ranade et al., 2014; Vilceanu and Stucky, 2010) . However, conflicting results have been published regarding the precise role of some of these channels in mechanotransduction (Drew et al., 2004; Dubin et al., 2017) . The only channel that has convincingly been shown to be required for mechanosensitivity of sensory neurons is PIEZO2. First, unlike the other aforementioned channels, PIEZO2 alone is sufficient to produce mechanotransduction currents when expressed in heterologous systems (Coste et al., 2010) . Moreover, PIEZO2 knockout mice have severe deficits in proprioception (Woo et al., 2015) and in gentle touch perception (Ranade et al., 2014) . Interestingly, PIEZO2 knockout mice do not seem to have problems detecting noxious mechanical stimuli and do develop hyperalgesia in the paw skin in the CFA model of inflammation (Ranade et al., 2014) . However, PIEZO2 is expressed in almost 50% of all sensory neurons (Ranade et al., 2014) , some of which express the heat-gated ion channel TRPV1 (Coste et al., 2010) , suggesting that PIEZO2 is also present in some nociceptors. Using qPCR and immunohistochemistry, we show that PIEZO2 is indeed expressed in some nociceptors, namely, in CHRNA3 + neurons ( Figures 7A and 7B) . Moreover, the current-voltage relationship together with the voltage dependence of the inactivation kinetics and the GsMTX4-sensitivity ( Figures  7C-7F) , and, most important, the observation that siRNA-mediated knockdown of PIEZO2 renders NGF-treated CHRNA3 + neurons insensitive to mechanical stimuli ( Figures 7G and 7H) Figure 7I , we propose that PIEZO2 is normally inhibited by a yet unknown protein and is released from this inhibition by another unidentified protein that is upregulated by NGF-TRKA-ERK1/2 signaling.
Conclusions
NGF signaling plays a central role in the development of mechanical hyperalgesia associated with inflammation. Despite the great efficacy of anti-NGF antibodies in alleviating pain, however, in 2010 all anti-NGF trials were placed on clinical hold for a period of almost 5 years, because of a high incidence of joint destruction in osteoarthritis patients receiving anti-NGF treatment and concerns regarding possible side effects on sympathetic neurons (Chang et al., 2016; Denk et al., 2017) . Our work, especially the identification of a nociceptor subpopulation that is particularly sensitive to NGF and that predominantly innervates tissues in which anti-NGF therapy has proved extremely efficacious, provides an invaluable framework for future studies that aim to further unravel the mechanism underlying NGFinduced hyperalgesia and studies aimed at developing drugs that selectively block the effects of NGF in sensory neurons and would thus potentially have fewer side effects than currently available anti-NGF drugs. Immunohistochemistry A detailed description of the immunostaining protocols and the antibodies that were used is provided in Supplemental Experimental Procedures.
Cell Culture DRG neurons from 8-to 12-week-old mice were cultured on glass coverslips coated with poly-L-lysine and laminin in DMEM-F12 medium supplemented with L-glutamine (2 mM), glucose (8 mg/mL), penicillin (200 U/mL)-streptomycin (200 mg/mL), and 5% fetal horse serum. Detailed information about the preparation of DRG cultures is provided in Supplemental Experimental Procedures.
Patch-Clamp Recordings
Whole-cell patch-clamp recordings were made at 20 C-24 C with an EPC10 amplifier (HEKA) and patch pipettes with a resistance of 2-4 MU. Neurons were clamped at a holding potential of À60 mV and stimulated with a series of mechanical stimuli in 1.6 mm increments with a fire-polished glass pipette (tip diameter 2-3 mm) that was positioned at an angle of 45 to the surface of the dish and moved with a velocity of 3.5 mm/ms by a piezo-driven micromanipulator (MM3A; Kleindiek Nanotechnik). Additional information is provided in Supplemental Experimental Procedures.
Retrograde Labeling
A detailed description of the retrograde labeling procedure is provided in Supplemental Experimental Procedures. Reverse Transcription and Real-Time qPCR mRNA expression levels of candidate mechanotransduction genes in CHRNA3 + neurons were determined from samples containing 20 CHRNA3 + neurons that were collected from DRG cultures by aspirating the cells into a patch-clamp pipette filled with 2-4 mL PBS containing 4 U/mL RNaseOUT (Thermo Fisher Scientific). cDNA synthesis was carried out directly on the sample using the Power SYBR Green Cells-to-CT Kit (Life Technologies) following the manufacturer's instructions. qPCRs were performed using FastStart Essential DNA Green Master (Roche) on a LightCycler 96 (Roche). Detailed information about primers and thermal cycle profile is provided in Supplemental Experimental Procedures.
Statistical Analysis
All statistical analyses were made using GraphPad Prism 5. The statistical tests that were used are mentioned in the figure legends and in the main text, respectively. To select the appropriate test, all datasets were tested for Gaussian distribution using the Kolmogorov-Smirnov test. N indicates the number of animals that were used; n indicates the number of cells. *p < 0.05, #p < 0.05, and xp < 0.05; **p < 0.01, ##p < 0.01, and xxp < 0.01; ***p < 0.001, ###p < 0.001, and xxxp < 0.001; ns, not significant (p > 0.05). 
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